CS4 Bone Lesions in Hormone Refractory Prostate Cancer (HRPC)

Japanese Journal of Urology - Japan
doi 10.5980/jpnjurol.97.118
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Japanese Urological Association

Related search

Hormone-Refractory Prostate Cancer

English

Therapeutic Approach to Hormone-Refractory Prostate Cancer

Oncology & Hematology Review (US)
2007English

Economic Evaluation of Denosumab Compared With Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients With Bone Metastases

Journal of Managed Care Pharmacy
2011English

Achieving Treatment Goals for Hormone-Refractory Prostate Cancer With Chemotherapy

Oncologist
Cancer ResearchMedicineOncology
2005English

Low-Dose Docetaxel in Combination With Dexamethasone for Hormone-Refractory Prostate Cancer

Japanese Journal of Urology
Urology
2011English

Androstenedione Is the Preferred Androgen Source in Hormone Refractory Prostate Cancer--Letter

Clinical Cancer Research
Cancer ResearchOncology
2014English

Palliative Radiotherapy for Local Progression of Hormone Refractory Stage D2 Prostate Cancer

Japanese Journal of Urology
Urology
1993English

Prostate-Specific Antigen Response to Withdrawal of Megestrol Acetate in a Patient With Hormone-Refractory Prostate Cancer

Mayo Clinic Proceedings
Medicine
1997English

Prostate-Specific Antigen Response to Withdrawal of Megestrol Acetate in a Patient With Hormone-Refractory Prostate Cancer

Mayo Clinic Proceedings
Medicine
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy